Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder
Status:
No longer available
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to allow patients with specific needs for inhaled insulin to
continue with inhaled insulin therapy using Technosphere Insulin after Exubera was withdrawn
from the market.